Figure 3From: Diversity of greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine Contribution of each antigen to coverage in relation to clonal complex. The numbers indicate the percentage of isolates predicted to be covered by each individual antigen. Isolates were defined as covered if they expressed PorA VR2 4 or had a MATS relative potency greater than the positive bactericidal threshold (PBT) for fHbp, NHBA, or NadA.Back to article page